Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

Overview of attention for article published in Pulmonary Therapy, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#12 of 188)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 2 news outlets

twitter: 13 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Comparing Rescue Medication Prescriptions in COPD Patients

Health Reporter, 13 Jul 2023

Stiolto: Dosage, side effects, cost, and more

Medical News Today, 31 Aug 2019

FDA warning This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA).